Fidelity Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $198K | Sell |
1,674
-347
| -17% | -$37.5K | ﹤0.01% | 3659 |
|
|
2026
Q1 | $210K | Sell |
2,021
-1,543
| -43% | -$163K | ﹤0.01% | 3474 |
|
|
2025
Q4 | $373K | Buy |
3,564
+2,599
| +269% | +$261K | ﹤0.01% | 3186 |
|
|
2025
Q3 | $89.2K | Buy |
965
+66
| +7% | +$5.78K | ﹤0.01% | 3713 |
|
|
2025
Q2 | $71.8K | Sell |
899
-1,021
| -53% | -$81.5K | ﹤0.01% | 3743 |
|
|
2025
Q1 | $166K | Buy |
1,920
+955
| +99% | +$81.3K | ﹤0.01% | 3326 |
|
|
2024
Q4 | $79.8K | Sell |
965
-92
| -9% | -$7.92K | ﹤0.01% | 3647 |
|
|
2024
Q3 | $91.9K | Buy |
1,057
+240
| +29% | +$20.5K | ﹤0.01% | 3513 |
|
|
2024
Q2 | $67.2K | Buy |
817
+16
| +2% | +$1.27K | ﹤0.01% | 3467 |
|
|
2024
Q1 | $64.2K | Sell |
801
-100
| -11% | -$7.75K | ﹤0.01% | 3463 |
|
|
2023
Q4 | $68.6K | Sell |
901
-121
| -12% | -$8.65K | ﹤0.01% | 3378 |
|
|
2023
Q3 | $74K | Buy |
1,022
+370
| +57% | +$28.4K | ﹤0.01% | 3209 |
|
|
2023
Q2 | $49.3K | Sell |
652
-30
| -4% | -$2.29K | ﹤0.01% | 3434 |
|
|
2023
Q1 | $51.8K | Sell |
682
-1
| -0.1% | -$77 | ﹤0.01% | 3437 |
|
|
2022
Q4 | $53.7K | Sell |
683
-277
| -29% | -$21.3K | ﹤0.01% | 3419 |
|
|
2022
Q3 | $68K | Sell |
960
-210
| -18% | -$15.7K | ﹤0.01% | 3378 |
|
|
2022
Q2 | $88K | Buy |
1,170
+1,008
| +622% | +$76.4K | ﹤0.01% | 3378 |
|
|
2022
Q1 | $13K | Buy |
162
+2
| +1% | +$155 | ﹤0.01% | 4162 |
|
|
2021
Q4 | $13K | Buy |
160
+48
| +43% | +$3.79K | ﹤0.01% | 3578 |
|
|
2021
Q3 | $9K | Sell |
112
-4
| -3% | -$323 | ﹤0.01% | 3654 |
|
|
2021
Q2 | $9K | Buy |
116
+15
| +15% | +$1.19K | ﹤0.01% | 3583 |
|
|
2021
Q1 | $8K | Sell |
101
-1
| -1% | -$78 | ﹤0.01% | 3448 |
|
|
2020
Q4 | $7K | Buy |
102
+2
| +2% | +$134 | ﹤0.01% | 3384 |
|
|
2020
Q3 | $6K | Buy |
100
+54
| +117% | +$3.53K | ﹤0.01% | 3285 |
|
|
2020
Q2 | $3K | Buy |
46
+45
| +4,500% | +$2.8K | ﹤0.01% | 3337 |
|
|
2020
Q1 | $0 | Sell |
1
-33
| -97% | -$2.01K | ﹤0.01% | 4116 |
|
|
2019
Q4 | $2K | Buy |
34
+27
| +386% | +$1.64K | ﹤0.01% | 3570 |
|
|
2019
Q3 | $0 | Buy |
7
+5
| +250% | +$288 | ﹤0.01% | 4132 |
|
|
2019
Q2 | $0 | Buy |
+2
| New | +$123 | ﹤0.01% | 4074 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | – | – | 4068 |
|
|
2018
Q4 | $0 | Sell |
2
-1
| -33% | -$67 | ﹤0.01% | 3991 |
|
|
2018
Q3 | $0 | Buy |
+3
| New | +$215 | ﹤0.01% | 3736 |
|
|
2014
Q1 | – | Sell |
-291,300
| Closed | -$15.6M | – | 2701 |
|
|
2013
Q4 | $15.6M | Buy |
+291,300
| New | +$14.6M | ﹤0.01% | 1804 |
|
|
2013
Q3 | – | Sell |
-231,400
| Closed | -$9.78M | – | 2660 |
|
|
2013
Q2 | $9.78M | Buy |
+231,400
| New | +$9.63M | ﹤0.01% | 1936 |
|
Other funds holding PJP
PAM
JGCM
Fidelity Investments's PJP Position: Q2 2026 in Review
Fidelity Investments reduced its Invesco Pharmaceuticals ETF (PJP) stake by 17% in Q2 2026, selling an estimated $37.5K and leaving 1,674 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #3659.
Fidelity Investments first reported a position in PJP in Q2 2013 and has held it in 33 quarters since. The position peaked at $15.6M in Q4 2013. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Fidelity Investments held 1,674 shares of Invesco Pharmaceuticals ETF worth $198K as of Q2 2026.
- Fidelity Investments sold 347 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $37.5K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3659 holding.
- Fidelity Investments first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 33 quarters since.
- Fidelity Investments's Invesco Pharmaceuticals ETF position peaked at $15.6M in Q4 2013.
- 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.